Picture of Aptamer Sciences logo

291650 Aptamer Sciences Income Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual income statement for Aptamer Sciences, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUSAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue408229269358243
Cost of Revenue
Gross Profit-802-974-1,080-1,222-1,620
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses3,6994,1514,3368,67812,450
Operating Profit-3,292-3,923-4,067-8,320-12,207
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-3,853-3,843-3,831-8,301-13,602
Provision for Income Taxes
Net Income After Taxes-3,853-3,843-3,831-7,116-13,602
Net Income Before Extraordinary Items
Net Income-3,853-3,843-3,831-7,116-13,602
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income-3,853-3,843-3,831-7,116-13,602
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-382-256-227-419-801
Dividends per Share
0